Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00NPP
|
||||
Former ID |
DAP000715
|
||||
Drug Name |
Zanamivir
|
||||
Synonyms |
GANA; GNA; Relenza; ZMR; Zanamavir; MODIFIED SIALIC ACID; Zanamivir hydrate; GG167; GR121167X; GG-167; GR-121167X; Relenza (TN); Zanamivir (USAN/INN); (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid; 4-Guanidino-NeueAc2en; 5-(acetylamino)-4-{[amino(imino)methyl]amino}-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; 5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid; ZNV
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Influenza virus [ICD10:J11.1] | Approved | [536361] | ||
Therapeutic Class |
Antiviral Agents
|
||||
Company |
GlaxoSmithKline
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H20N4O7
|
||||
Canonical SMILES |
CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N
|
||||
InChI |
1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
|
||||
InChIKey |
ARAIBEBZBOPLMB-UFGQHTETSA-N
|
||||
CAS Number |
CAS 139110-80-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
10295, 626318, 7847966, 7891225, 7980905, 8034575, 12014758, 14716772, 14801980, 14851079, 26709110, 26717829, 43118193, 46386819, 46391390, 46394328, 46508581, 48416708, 49738104, 53801134, 55161598, 57314153, 79665754, 81058936, 93166507, 104234237, 104321823, 118043618, 123109441, 126666923, 127446835, 134338003, 137003633, 138943627, 139483079, 144071866, 144203211, 144205743, 151980432, 152133958, 152258463, 160647298, 160963903, 162176829, 163981441, 164235531, 164831563, 170464662, 172089037, 175267628
|
||||
ChEBI ID |
ChEBI:50663
|
||||
SuperDrug ATC ID |
J05AH01
|
||||
SuperDrug CAS ID |
cas=139110808
|
||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | Neuraminidase | Target Info | Inhibitor | [535258], [536654] | |
KEGG Pathway | Other glycan degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.